Search
Home News > Results of the Study on Cross-Border Healthcare

Results of the Study on Cross-Border Healthcare

Would you like to know more about how EU patients may access healthcare in another EU country and be reimbursed for care abroad by their home country? Then read the results of the Study on Enhancing implementation of the Cross-Border Healthcare Directive 2011/24/EU to ensure patient rights in the EU.

This study was carried carried out by Spark Legal Network, Technopolis Group and Ecorys NL for the European Commission (DG SANTE). The purpose of the study was to support the European Commission’s (DG SANTE) work to deepen the analysis of difficulties encountered by patients to access healthcare in another Member State, and the shortcomings in the practical application of Directive 2011/24/EU. Specifically, the Study aimed at:

i) identifying options for improving the consistency and transparency in the application of the Directive;ii) mapping and analysing information from the 27 Member States as well as EEA countries on specific areas of the Directive’s practical implementation (e.g., Prior Authorisation for healthcare abroad, administrative procedures for patients, etc.); andiii) developing an intervention logic and critical review of existing monitoring indicators for future evaluation of the Directive (2019 Toolbox).

In this context, Guiding Principles were developed to provide recommendations to streamline and simplify Prior Authorisation and other administrative procedures.We are very proud to present our full Study report here.

Subscribe to our newsletter

Our newsletter contains information about Spark’s finalised and ongoing projects, activities and conferences we attend. In the newsletter we may also send you advertising information about services we offer. You can withdraw your consent to receive our newsletter at any time. For details, please consult our Privacy Policy.

We use MailChimp as our marketing platform. By subscribing, you aknowledge that your information will be transferred toMailChimp for processing. Learn more about MailChimp's privacy practices.